Lindbrook Capital’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $20.1K | Buy |
6,021
+3,116
| +107% | +$10.4K | ﹤0.01% | 1352 |
|
|
2024
Q4 | $21.5K | Sell |
2,905
-79
| -3% | -$585 | ﹤0.01% | 1247 |
|
|
2024
Q3 | $28K | Buy |
2,984
+292
| +11% | +$2.74K | ﹤0.01% | 1104 |
|
|
2024
Q2 | $21.6K | Buy |
2,692
+44
| +2% | +$353 | ﹤0.01% | 1207 |
|
|
2024
Q1 | $39.2K | Buy |
2,648
+35
| +1% | +$519 | ﹤0.01% | 884 |
|
|
2023
Q4 | $21.2K | Buy |
2,613
+1,079
| +70% | +$8.77K | ﹤0.01% | 1145 |
|
|
2023
Q3 | $6.98K | Buy |
1,534
+178
| +13% | +$810 | ﹤0.01% | 1595 |
|
|
2023
Q2 | $9.55K | Sell |
1,356
-1,114
| -45% | -$7.84K | ﹤0.01% | 1494 |
|
|
2023
Q1 | $15.1K | Sell |
2,470
-737
| -23% | -$4.5K | ﹤0.01% | 1209 |
|
|
2022
Q4 | $20.5K | Buy |
3,207
+2,232
| +229% | +$14.3K | ﹤0.01% | 1051 |
|
|
2022
Q3 | $9K | Sell |
975
-45
| -4% | -$415 | ﹤0.01% | 1372 |
|
|
2022
Q2 | $11K | Sell |
1,020
-89
| -8% | -$960 | ﹤0.01% | 1215 |
|
|
2022
Q1 | $18K | Sell |
1,109
-16
| -1% | -$260 | ﹤0.01% | 1045 |
|
|
2021
Q4 | $21K | Buy |
1,125
+1,053
| +1,463% | +$19.7K | ﹤0.01% | 998 |
|
|
2021
Q3 | $2K | Sell |
72
-48
| -40% | -$1.33K | ﹤0.01% | 1552 |
|
|
2021
Q2 | $3K | Buy |
+120
| New | +$3K | ﹤0.01% | 1475 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1897 |
|
|
2020
Q3 | – | Sell |
-1,000
| Closed | -$27K | – | 1794 |
|
|
2020
Q2 | $27K | Buy |
+1,000
| New | +$27K | 0.01% | 522 |
|
|
2020
Q1 | – | Sell |
-500
| Closed | -$14K | – | 1773 |
|
|
2019
Q4 | $14K | Buy |
+500
| New | +$14K | ﹤0.01% | 829 |
|
|
2019
Q2 | – | Sell |
-750
| Closed | -$7K | – | 1448 |
|
|
2019
Q1 | $7K | Buy |
+750
| New | +$7K | ﹤0.01% | 987 |
|